Literature DB >> 16821116

Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by beta-amyloid peptide 25-35 in young mice.

J Ahn1, M Um, W Choi, S Kim, T Ha.   

Abstract

Amyloid beta protein (Abeta) may be involved in the progression of Alzheimer's disease (AD), by acting as a neurotoxin and eliciting oxidative stress. This study was designed to determine the effects of Glycyrrhiza uralensis Fisch. water extract (GWE) on the cognitive deficits and oxidative stress induced by the administration of Abeta(25-35) in mice. Mice in two of the four animal groups were fed an experimental diet containing either 0.5 or 1% GWE for the entire 6-week experimental period. Control mice and a further experimental group were fed a non-GWE diet. Abeta(25-35) was administered to the three experimental groups by intracerebroventricular (i.c.v.) injection (10 microg/10 microl/mouse) once per week in weeks 5 and 6 of the experimental period. Behavioral changes were assessed using both a passive avoidance (after the injection of Abeta(25-35) in week 5) and the Morris water-maze tests (after the injection of Abeta(25-35) in week 6). Control animals were administered vehicle alone. The prolonged consumption of a diet containing GWE ameliorated the cognitive deficits caused by the i.c.v. injections of Abeta(25-35). Treatment with Abeta(25-35) led to higher concentrations of thiobarbituric acid reactive substances in the brain, and GWE attenuated this response. There was a decrease in catalase activity in the group provided with 1% GWE. Acetylcholinesterase activity was significantly reduced in the brains of all GWE-treated animals compared to that in the non-GWE-fed experimental group. These results suggest that GWE exerts a protective effect against the cognitive impairments often observed in AD, and that in mice this effect is mediated by antioxidant actions against oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821116     DOI: 10.1007/s10522-006-9023-0

Source DB:  PubMed          Journal:  Biogerontology        ISSN: 1389-5729            Impact factor:   4.277


  9 in total

1.  Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25-35 or Aβ1-40 peptide in rats.

Authors:  Yu-Fang Cheng; Chuang Wang; Huan-Bing Lin; Yun-Feng Li; Ying Huang; Jiang-Ping Xu; Han-Ting Zhang
Journal:  Psychopharmacology (Berl)       Date:  2010-07-17       Impact factor: 4.530

2.  Inhibition of phosphodiesterase-4 reverses the cognitive dysfunction and oxidative stress induced by Aβ25-35 in rats.

Authors:  Yeye Zhuo; Haibiao Guo; Yufang Cheng; Chuang Wang; Canmao Wang; Jingang Wu; Zhengqiang Zou; Danna Gan; Yiwen Li; Jiangping Xu
Journal:  Metab Brain Dis       Date:  2016-02-27       Impact factor: 3.584

Review 3.  Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease.

Authors:  Agnes Simonyi; Yan He; Wenwen Sheng; Albert Y Sun; W Gibson Wood; Gary A Weisman; Grace Y Sun
Journal:  Mol Neurobiol       Date:  2010-03-02       Impact factor: 5.590

4.  Neuroprotective Effect of 2-Aminoethoxydiphenyl Borate (2-APB) in Amyloid β-Induced Memory Dysfunction: A Mechanistic Study.

Authors:  Pavan Thapak; Pragyanshu Khare; Mahendra Bishnoi; Shyam Sunder Sharma
Journal:  Cell Mol Neurobiol       Date:  2020-11-21       Impact factor: 5.046

5.  Traditional chinese medicine for senile dementia.

Authors:  Zhihong Lin; Jie Gu; Jin Xiu; Tingyan Mi; Jie Dong; Jyoti Kumar Tiwari
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-25       Impact factor: 2.629

6.  Therapeutic Effect of Yi-Chi-Tsung-Ming-Tang on Amyloid β-Induced Alzheimer's Disease-Like Phenotype via an Increase of Acetylcholine and Decrease of Amyloid β.

Authors:  Chung-Hsin Yeh; Ming-Tsuen Hsieh; Chi-Mei Hsueh; Chi-Rei Wu; Yi-Chun Huang; Jiunn-Wang Liao; Kuan-Chih Chow
Journal:  Evid Based Complement Alternat Med       Date:  2012-06-13       Impact factor: 2.629

7.  Screening of sleep assisting drug candidates with a Drosophila model.

Authors:  Yan-Ying Wang; Wei-Wei Ma; I-Feng Peng
Journal:  PLoS One       Date:  2020-07-29       Impact factor: 3.240

8.  Suppressive effect of glycyrrhizic acid against lipopolysaccharide-induced neuroinflammation and cognitive impairment in C57 mice via toll-like receptor 4 signaling pathway.

Authors:  Wenfeng Liu; Shun Huang; Yonglian Li; Kun Zhang; Xi Zheng
Journal:  Food Nutr Res       Date:  2019-04-29       Impact factor: 3.894

Review 9.  Traditional Oriental Medicines and Alzheimer's Disease.

Authors:  Seong Gak Jeon; Eun Ji Song; Dongje Lee; Junyong Park; Yunkwon Nam; Jin-Il Kim; Minho Moon
Journal:  Aging Dis       Date:  2019-04-01       Impact factor: 6.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.